Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 344 followers
Latest posts
Last updated about 3 hours ago
Enveda reaps $311M series E to feed ambition to become a ‘household name’
about 3 hours ago
Enveda has raised a $311 million series E round, positioning the nature-derived...
Boehringer adds $250M to value of Variant pact by expanding into cardiovascular disease
about 3 hours ago
Boehringer Ingelheim has dived deeper into its collaboration with Variant Bio by...
Trump's Department of War bets $47M on Flagship biotechs to develop countermeasures
about 3 hours ago
The Department of War has awarded Flagship Pioneering $47 million to develop...
Immunovant ends cutaneous lupus program after phase 2 flop
about 3 hours ago
Immunovant has stopped development of IMVT-1402 in cutaneous lupus erythematosus after failing...
Immunovant ends cutaneous lupus program after phase 2 flop
about 4 hours ago
Immunovant has stopped development of IMVT-1402 in cutaneous lupus erythematosus after failing...
GSK aiming to ‘balance West and East’ after Hansoh deal success showed China’s potential
about 9 hours ago
GSK has been operating a strategy of “balancing the West and the...
Anaconda Biomed snares $56M in funding for endovascular tech
about 10 hours ago
Medtech startup Anaconda Biomed has hauled in $53 million to help finish...
Roche’s phase 3 win tees up fight with Novartis for blockbuster kidney disease market
about 10 hours ago
Roche has reported a phase 3 win for sefaxersen in kidney disease...
Novartis secures new radioligand in $900M deal as competition strengthens
about 24 hours ago
As an imposing new competitor begins to take shape, radiopharma leader Novartis...
Cordis’ sirolimus drug-coated balloon earns FDA approval as a breakthrough device
1 day ago
The FDA gave the green light to a first and only sirolimus...
Celldex monoclonal antibody rebounds with pair of phase 3 wins for chronic skin condition
1 day ago
Celldex touted a double phase 3 trial win in patients with treatment-refractory...
Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win
1 day ago
An investigational drug for the autoimmune condition Sjögren's disease has scored a...